礼来公司周二表示，其实验性药物在后期临床试验中帮助患有2型糖尿病和肥胖症的成年人平均减掉了近21%的体重。
Eli Lilly said on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.
路透社
礼来实验性药物在糖尿病试验中使体重减轻21%Lilly's experimental drug cuts weight by 21% in diabetes trial
点「原文对照」整页切到原文，或双击某段只看那段的原文。